Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP459591.RAQfHunGzta1p0TVnZHYS2f57ERTzLnL6u15Ze_n2ZXT0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP459591.RAQfHunGzta1p0TVnZHYS2f57ERTzLnL6u15Ze_n2ZXT0130_assertion type Assertion NP459591.RAQfHunGzta1p0TVnZHYS2f57ERTzLnL6u15Ze_n2ZXT0130_head.
- NP459591.RAQfHunGzta1p0TVnZHYS2f57ERTzLnL6u15Ze_n2ZXT0130_assertion description "[Pharmacological targeting of these proinflammatory pathways using selective receptor antagonists, or the use of transgenic mice with perturbed cell signaling, demostrated that the activation of IL-1R type 1 and TLR4 by their respective endogenous ligands, i.e., interleukin (IL)-1b and High Mobility Group Box 1, is implicated in the precipitation and recurrence of experimentally induced seizures in rodents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP459591.RAQfHunGzta1p0TVnZHYS2f57ERTzLnL6u15Ze_n2ZXT0130_provenance.
- NP459591.RAQfHunGzta1p0TVnZHYS2f57ERTzLnL6u15Ze_n2ZXT0130_assertion evidence source_evidence_literature NP459591.RAQfHunGzta1p0TVnZHYS2f57ERTzLnL6u15Ze_n2ZXT0130_provenance.
- NP459591.RAQfHunGzta1p0TVnZHYS2f57ERTzLnL6u15Ze_n2ZXT0130_assertion SIO_000772 21967368 NP459591.RAQfHunGzta1p0TVnZHYS2f57ERTzLnL6u15Ze_n2ZXT0130_provenance.
- NP459591.RAQfHunGzta1p0TVnZHYS2f57ERTzLnL6u15Ze_n2ZXT0130_assertion wasDerivedFrom befree-20150227 NP459591.RAQfHunGzta1p0TVnZHYS2f57ERTzLnL6u15Ze_n2ZXT0130_provenance.
- NP459591.RAQfHunGzta1p0TVnZHYS2f57ERTzLnL6u15Ze_n2ZXT0130_assertion wasGeneratedBy ECO_0000203 NP459591.RAQfHunGzta1p0TVnZHYS2f57ERTzLnL6u15Ze_n2ZXT0130_provenance.